A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
Scientists scanned the brains of people who took psilocybin, including a member of the research team. The scans showed how the drug disrupts key networks, potentially enhancing brain plasticity.
A prominent brain scientist took psilocybin as part of his own study on how it affects the brain. The results of his findings could help researchers to further unlock its "therapeutic potential."